• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • Comprehensive Eye Exams
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

COVID-19 associated with a purtscher-like retinopathy


OCT showed inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.

COVID-19 associated with a purtscher-like retinopathy

Marco Pastore, MD, from the Eye Clinic, Department of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, Italy, and colleagues reported a patient with acute painless vision loss in both eyes. The visual acuity decreased to counting fingers. The appearance of the retina and optic disc was found to be associated with the SARS-CoV-2 virus.

The investigators described that the ophthalmoscopic examination showed “multiple polygonal areas of retinal whitening at the posterior pole and around the optic disc associated with mild optic disc edema, nerve fiber layer infarcts, and macular edema with pseudo-cherry red spot” in both eyes.

The results of optical coherence tomography imaging showed “inner retinal hyperreflectivity, diffuse retinal thickening with intraretinal fluid, and a serous macular detachment.”

The investigators diagnosed an paracentral acute middle maculopathy that was associated with capillary nonperfusion of the intermediate and deep capillary plexuses.

The patient underwent testing for the SARS-CoV-2 virus, and polymerase chain reaction confirmed the infection.

Laboratory tests showed that both the C-reactive protein and D-dimer levels were increased. The patient was negative for any infectious diseases. The authors diagnosed Purtscher-like retinopathy associated with COVID-19. Treatment included intravenous methylprednisone (1,000-mg dose) for 7 days followed by oral corticosteroids.

Two months after the initial presentation, the vision improved from counting fingers to 20/32 and 20/25 in the right and left eyes, respectively. In addition, the authors reported that the detachment resolved with focal subfoveal ellipsoid zone disruption and reduced hyperreflectivity in the inner nuclear layer and outer plexiform layer.


Pastore MR, Furlanis G, Tognetto D. Bilateral Purtscher-like retinopathy associated with SARS-CoV-2 infection. JAMA Ophthalmol 2022;140(2):e214979. doi:10.1001/jamaophthalmol.2021.4979

Related Videos
Edmund Tsui, MD, details what insights swept-source anterior segment OCT images may give to determining eye inflammation
Michael Chaglasian, OD, details success of new OCT device at the ARVO 2024 meeting
Deborah Ferrington details a session on mitochondrial maintenance and retinal health in patients with AMD at ARVO 2024
Dr. John Sheppard discusses results from trials testing the efficacy of eye drops to treat dry eye disease
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Steven Ferrucci, OD, FAAO - AAOpt
© 2024 MJH Life Sciences

All rights reserved.